Skip to content

Effect of electro-acupuncture of jiaji-acupoints on spinal cord ischemia-reperfusion injury after cervical decompression surgery in patients with cervical spondylotic myelopathy: a randomized controlled trial

Effect of electro-acupuncture of jiaji-acupoints on spinal cord ischemia-reperfusion injury after cervical decompression surgery in patients with cervical spondylotic myelopathy: a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-POR-15007274
Enrollment
Unknown
Registered
2015-10-26
Start date
2016-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Spondylotic Myelopathy

Interventions

experimental group:electro-acupuncture of jiaji-acupoints
control group:none electro-acupuncture of jiaji-acupoints

Sponsors

Shaoxing Hospital of TCM affiliated to Zhejiang Chinese Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) clear diagnosis of CSM patients, aged ranged from 35 to 65 years old; (2) undergoing elective anterior or posterior decompression surgery; (3) agreed to participate in research and signed the informed consent form; (4) with good adherence and can stick to treatment by the regulation and cooperate with the doctor's follow-up.

Exclusion criteria

Exclusion criteria: (1) Patients with severe health problems, such as heart, liver, kidney and lung affect curative effect observation; (2) Patients with history of previous cervical spine surgery; (3) Patients with neck skin infection; (4) Patients with mental disorders, difficult to cooperate with treatment; (5) Patients with implanted pacemaker in the body; (6) Patients with fear of electric acupuncture and invalid to the explanation.

Design outcomes

Primary

MeasureTime frame
Japanese Orthopaedic Association (JOA) scale;somatosensory evoked potential;

Secondary

MeasureTime frame
Serum level of S-100B and neuron-specific enolase;

Countries

China

Contacts

Public ContactXia Bingjiang
zhongxiyijieheguke@163.com13754381615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026